250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Ireland

A list of 50 angel investors and VC funds that invest in Medical startups based in Ireland. We rank investors based on the number of investments they made in Medical companies from Ireland. We update this investor list every month.

Top 50 Medical Startup Investors in Ireland

Investor Medical Ireland investments
Enterprise Ireland 29
AIB Seed Capital Fund 9
Western Development Commission 9
HBAN 7
HBAN Medtech Syndicate 7
Elkstone Capital Partners 7
Irrus Investments 7
Act Venture Capital 6
Furthr VC 6
Atlantic Bridge 6
SOSV 5
Business Venture Partners 5
Kernel Capital 5
Fountain Healthcare Partners 5
Seroba Life Sciences 4
NDRC 4
Enterprise Equity 3
Medtech Syndicate Nominee 3
SVG Ventures 2
Oyster Capital Partners 2
Partisan Management Group 2
EIT Health 2
Ascentifi 2
Delta Partners 2
Chip Hance 2
Boole 2
Life Sciences Fund Amsterdam 2
Cantor Fitzgerald 2
SVG Ventures 2
Glanzmann Enterprises 2
Cliff Emmons 1
HBM-MedFocus 1
Malin Corporation 1
Business Growth Fund 1
Eamon Brady 1
Street Capital 1
Boole Investment Syndicate 1
Bank of Scotland 1
Inventages Venture Capital Investment Inc. 1
Nadav Ben-Chanoch 1
Moffett Investment Holdings 1
European Investment Bank 1
HealthCap 1
Bpifrance 1
Medicxi 1
Keiretsu Forum Northwest 1
EarlyBird 1
John O’Shaughnessy 1
Invest Northern Ireland 1
KBI Biopharma 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 19 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Giyst — Giyst's revolutionary summarization engine seamlessly connects with video platforms, generating automated video summaries. Giyst also generates data to improve search results and make useful content recommendations.
  • Assiduous — The AI-enabled platform to do the heavy-lifting for business owners seeking finance for their aspiring growth company.
  • Tao Climate — Carbon removal services. We use hemp, sustainable housing, and nextgen MRV to deliver fast, measurable impacts on climate and society.
AIB Seed Capital Fund VC Fund · Dublin, Dublin, Ireland
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Funding Round, Series A
  • Ireland, United States, Jersey
Portfolio highlights
  • NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Western Development Commission VC Fund · Ballaghaderreen, Roscommon, Ireland · 2 investments in the past 12 months
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Funding Round, Series A
  • Ireland, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
  • Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
HBAN VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more
Investment focus
  • Health Care, Software, Medical Device
  • Seed, Funding Round, Series A
  • Ireland, United Kingdom, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Klearcom — Klearcom tests the full customer call path from domestic phone number through the IVR Interactive Voice Response for connectivity and voice quality, validating voice call paths ensuring the connection between customer and agent is always reachable and accessible, software telecommunications IVR testing voice
  • GREYSCOUT — Need brand protection? Our best brand protection software monitors & removes unauthorized listings, helping businesses fight online counterfeiting.
HBAN Medtech Syndicate VC Fund · 4 investments in the past 12 months
HBAN Medtech Syndicate
Show more
Investment focus
  • Medical Device, Medical, Health Care
  • Seed, Funding Round, Series B
  • Ireland
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Elkstone Capital Partners VC Fund · Dublin, Dublin, Ireland · 10 investments in the past 12 months
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Funding Round, Series A
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Numra — Numra is an artificial intelligence automation for financial operations.
  • Jamango — Create and play for free in Jamango! Play with our block-based tools to make anything or explore a library of games and worlds instantly. No downloads.
  • Wellola — Wellola connects clinics & their own clients, anywhere, anytime. It is designed for the forward-thinking healthcare professional. Our cloud-based platform offers secure video-consultation software combined with simple payment/practice management facilities.
Irrus Investments VC Fund · Limerick, Limerick, Ireland · 2 investments in the past 12 months
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more
Investment focus
  • Medical Device, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • Ireland, Sweden, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Bluedrop Medical — Evidence shows regular inspection of the feet can greatly reduce the risk of developing a diabetic foot ulcer (DFU).
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Act Venture Capital VC Fund · Dublin, Dublin, Ireland · 5 investments in the past 12 months
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • GridBeyond — Endeco's Energy ManagementSystem (EMS) provides wirelessenergy management and controlsystems for retail, commercial andindustrial users. Applications includebuilding control, refrigeration control,demand management, priceresponse, energy efficiency, anddemand response. Our automatedwireless systems seamlesslyintegrate intoyour existingoperations and/or BuildingManagement System (BMS) withoutany training of retail staff required.
  • CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
  • Mavarick AI — Explore Mavarick AI's Carbon Accounting Software Platform. Get accurate carbon emissions accounting data and generate auditable reports with ease.
Furthr VC VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.
Show more
Investment focus
  • Medical, Medical Device, Health Care
  • Seed, Funding Round, Pre-Seed
  • Ireland
Portfolio highlights
  • GREYSCOUT — Need brand protection? Our best brand protection software monitors & removes unauthorized listings, helping businesses fight online counterfeiting.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Atlantic Bridge VC Fund · Dublin, Dublin, Ireland · 5 investments in the past 12 months
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Series A, Series B, Funding Round
  • United States, Ireland, United Kingdom
Portfolio highlights
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • Cambridge Mechatronics — Cambridge Mechatronics (CML) is a high technology design and engineering company based in Cambridge, UK. We specialise in pioneering and developing cutting-edge mechatronic platform technology from concept to mass production. We achieve this through technology licensing or partnerships with global manufacturing corporations. Our intellectualproperty portfolio consists of over 100 granted patents that we can exploit.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Business Venture Partners VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more
Investment focus
  • Health Care, Information Technology, Medical
  • Seed, Funding Round, Series A
  • Ireland, Luxembourg, The Netherlands
Portfolio highlights
  • OOHPod — Self service parcel lockers for personal and business customers. Choose from a range of plans to suit you. Pay As You Go, Monthly and Premium Subscriptions available. Find your nearest OOHPod parcel locker and start using your out of home flexible address today.
  • Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Kernel Capital VC Fund · Cork, Cork, Ireland
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United Kingdom, France
Portfolio highlights
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
  • Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
  • Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.
Fountain Healthcare Partners VC Fund · Dublin, Dublin, Ireland
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • Ireland, United States, France
Portfolio highlights
  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
  • Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.
Seroba Life Sciences VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
  • Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
  • Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
NDRC VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Convertible Note
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Nory AI — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
  • Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
  • Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Enterprise Equity VC Fund · Dundalk, Louth, Ireland
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more
Investment focus
  • Software, Information Technology, Medical Device
  • Funding Round, Seed, Series B
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Medtech Syndicate Nominee VC Fund
Medtech Syndicate Nominee
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A, Funding Round
  • Ireland
Portfolio highlights
  • Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
SVG Ventures VC Fund · Los Gatos, California, United States
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more
Investment focus
  • AgTech, Agriculture, Farming
  • Pre-Seed, Seed, Funding Round
  • United States, Canada, Ireland
Portfolio highlights
  • FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
  • Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
  • Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.
Oyster Capital Partners VC Fund · Blackrock, Dublin, Ireland
Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.
Show more
Investment focus
  • Software, Medical Device, Enterprise Software
  • Series A, Funding Round, Seed
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
  • Ooodles — The service platform to get premium tech products for you, your business and your employees
  • &Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.
Partisan Management Group VC Fund · Evergreen, Colorado, United States
Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round, Series A, Series B
  • United States, Ireland
Portfolio highlights
  • TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
  • Enable Injections — Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject upto 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions.Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.
  • Ponce De Leon Pharmaceuticals — Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. Thisformulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.
EIT Health VC Fund · Munich, Bayern, Germany
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Grant, Pre-Seed, Seed
  • United Kingdom, Spain, Ireland
Portfolio highlights
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
  • Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Ascentifi VC Fund · Galway, Galway, Ireland · 2 investments in the past 12 months
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Funding Round, Series A
  • Ireland
Portfolio highlights
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • Bluedrop Medical — Evidence shows regular inspection of the feet can greatly reduce the risk of developing a diabetic foot ulcer (DFU).
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Delta Partners VC Fund · Leopardstown, Dublin, Ireland · 5 investments in the past 12 months
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • inspeq ai — Empower your Gen AI projects with Inspeq AI. Our platform enables financial institutions to responsibly deploy and manage generative AI applications.
  • ZeroMission — ZeroMission is a technology focused provider of integrated data for intelligent fleet electrification planning, operations and reporting.
  • MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.
Chip Hance Angel
Chip Hance
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Ireland
Portfolio highlights
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Boole VC Fund
Boole
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Seed, Funding Round
  • Ireland
Portfolio highlights
  • Incereb — Lifelines Neuro offers exceptional infant EEG electrodes with Incereb. Learn more about this wonderful device for neonates in the NICU.
  • ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
Life Sciences Fund Amsterdam VC Fund · Amsterdam, Noord-Holland, The Netherlands
Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.
Show more
Investment focus
  • Medical Device, Medical, Communities
  • Series A, Funding Round, Private Equity
  • Ireland, The Netherlands
Portfolio highlights
  • Sigmascreening — At Sigmascreening, an Amsterdam based medical device company, they focus on the development of new products in the area of breast cancer screening. Sigmascreening is established as a spin-off company from the Academic Medical Center Amsterdam (AMC Amsterdam). They have several products under development, which are all aimed at improving digitalmammography, the “golden standard” in breast cancer screening.
  • Neurent Medical — Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases.
Cantor Fitzgerald VC Fund · New York, New York, United States · 2 investments in the past 12 months
Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. Thiscommitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Post-IPO Equity, Series B, Series A
  • United States, Canada, Ireland
Portfolio highlights
  • View — View is the leader in smart building technologies that transform buildings to improve human health and experience, reduce energy consumption and carbon emissions, and generate additional revenue for building owners. View Smart Windows use artificial intelligence to automatically adjust in response to the sun, increasing access to natural light andunobstructed views while eliminating the need for blinds and minimizing heat and glare. Every View installation includes a cloud-connected smart building platform that can be extended to reimagine the occupant experience. View is installed and designed into over 90 million square feet of buildings, including offices, hospitals, airports, educational facilities, hotels, and multifamily residences. For more information, please visit: www.view.com.
  • REIGO Investments — Reigo Investments is a technology company reshaping the real estate investment space. Focusing on the senior hard money lending US market, the company employs data science to improve performance, reduce defaults, and reduce underwriting time dramatically.
  • Strive Asset Management — Strive is an asset management firm whose mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics.
SVG Ventures VC Fund · Los Gatos, California, United States · 4 investments in the past 12 months
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more
Investment focus
  • AgTech, Agriculture, Farming
  • Pre-Seed, Seed, Funding Round
  • United States, Canada, Ireland
Portfolio highlights
  • scoutlabs — We're building the world's densest digital trap network to accurately gauge insect pest pressure. This helps millions of farmers in precisely combating crop-eating insects, accelerating a transition to more sustainable methods. Good for the farmer, the environment and for our food security
  • Cynomys — Soluzioni IOT di monitoraggio ambientale per allevamenti e aziende
  • Verdi Expeditions — Verdi is building the world's first truly scalable platform for farm automation. We work with the world's largest food brands to grow better and more sustainable crops.
Glanzmann Enterprises VC Fund
Glanzmann Enterprises
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Ireland
Portfolio highlights
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Cliff Emmons Angel
Cliff Emmons is the Chief Executive Officer of Oxys.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed
  • Ireland
Portfolio highlights
  • Gasgon Medical — Medical device start-up | Improving healthcare with advanced IV technology | Infused With Confidence | Cork, Ireland.
HBM-MedFocus VC Fund
HBM-MedFocus
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Ireland, United States
Portfolio highlights
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Viseon — Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgeryprocedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.
Malin Corporation VC Fund · Dublin, Dublin, Ireland
Malin Corporation plc (“Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut and Research Triangle, North Carolina, USA.Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise toprivate, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.
Show more
Investment focus
  • Biotechnology, Health Care, Biopharma
  • Funding Round, Series B, Series C
  • United States, United Kingdom, Ireland
Portfolio highlights
  • CG Oncology — CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder saving therapeutics for patients with bladder cancer.
  • Poseida Therapeutics — Poseida Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies with the capacity to cure cancers and genetic diseases.
  • Xenex — Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections.The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load oftenassociated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S.Xenex was founded in 2009 and headquartered in San Antonio, Texas.
Business Growth Fund VC Fund · London, England, United Kingdom · 27 investments in the past 12 months
BGF invests in hundreds of businesses from an evergreen balance sheet. But we offer more than just growth capital. Find out what makes us different.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Funding Round, Series A, Private Equity
  • United Kingdom, Ireland, United States
Portfolio highlights
  • Purple — Increase revenues & reduce costs with our Indoor Location Services platform that includes Guest WiFi, Digital Wayfinding & Asset Tracking solutions
  • Victorian Sliders — We are Victorian Sliders, the largest manufacturer of vertical sliding windows in Europe and exclusive providers of ECOSlide sash windows.
  • Operational Solutions — At OSL, we produce market-leading counter drone solutions to create safer spaces across a range of complex sites and environments.
Eamon Brady Angel · Galway, Galway, Ireland
Eamon Brady is the CEO of WhiteSwell. Eamon Brady attended Athlone Institute of Technology.
Show more
Investment focus
  • Medical, Health Diagnostics
  • Funding Round
  • Ireland
Portfolio highlights
  • Ceroflo — Ceroflo offers revolutionary advancement in the treatment of Intracranial Atherosclerotic Disease.
Street Capital VC Fund · Toronto, Ontario, Canada
Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesn’t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since we’re primarily focused on the mortgage broker origination channel, you’re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.
Show more
Investment focus
  • Medical, Automotive, Biotechnology
  • Seed, Funding Round
  • Ireland, United States
Portfolio highlights
  • Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
  • Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.
Boole Investment Syndicate VC Fund · Cork, Cork, Ireland · 2 investments in the past 12 months
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more
Investment focus
  • Medical Device, SaaS, EdTech
  • Seed, Funding Round
  • Ireland, United States
Portfolio highlights
  • FeelTect — Connected health technology for disruptive improvements to wound care
  • Hooke Bio — Hooke Bio is a new Pharmaceutical company operating in the preclinical to early stages of drug discovery. It draws its strength from the close co-operation it has between its biologists and engineers. The engineers design, patent and test new microfluidic technology: the scientists apply the technology to finding new therapeutics.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Bank of Scotland VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 2 investments in the past 12 months
At Bank of Scotland, whether you're looking for a bank account, credit card, loan, mortgage or something else, we're here to help you.
Show more
Investment focus
  • Manufacturing, Semiconductor, ISP
  • Funding Round, Series B, Post-IPO Debt
  • United Kingdom, United States, Ireland
Portfolio highlights
  • Ramsdens — Ramsdens is a growing, diversified, financial services provider and retailer, operating in the four core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery.
  • Briar Homes — Briar Homes is a highly skilled private home builder with extensive experience in the industry.
  • Gateley Plc — Passionate problem solvers, we get our kicks from finding the right answers and getting our legal and business clients where they need to be.
Inventages Venture Capital Investment Inc. VC Fund · London, England, United Kingdom
Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Funding Round
  • United States, United Kingdom, Canada
Portfolio highlights
  • Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
  • XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
  • Ripple Foods — Ripple Foods offers a nutritious & delicious milk alternative that is 100% dairy-free, vegan, nut-, lactose- & gluten-free. Discover more about Ripple milk!
Nadav Ben-Chanoch Angel · Miami, Florida, United States · 18 investments in the past 12 months
Nadav Ben-Chanoch - Partner @ Pareto Holdings
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Moffett Investment Holdings VC Fund
Moffett Investment Holdings is an investment firm
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Series B
  • Ireland
Portfolio highlights
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 15 investments in the past 12 months
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Debt Financing, Post-IPO Debt, Funding Round
  • France, Germany, The Netherlands
Portfolio highlights
  • Rohlik — Rohlik is an innovative grocery delivery startup that offers a 90-minute same-day delivery service. Since its inception, Rohlik has been growing and is on track to EUR 300 mil. revenues in 2020. Rohlík was founded in 2014 by Marek Sacha and Tomas Cupr and is headquartered in Karlín, Hlavni mesto Praha, Czech Republic.
  • Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
  • ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in the past 12 months
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 78 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • Tracklab — Tracklab is a B2B compliance software helping regulated companies manage their mandatory supplier documentations.
  • Jared — Jared is an early-stage fintech company that has developed the first intelligent financial assistant for the B2C Market that addresses the need for daily support in understanding and anticipating each individual’s financial needs and objectives.Managing finances is everyone's business, regardless of the amount of their incomes or wealth.Jared comes up to balance deep inequalities in our finances due to differences in financial education. Even if many support and advice solutions do exist (financial advisors, bank advisors, Agregators & Asset Management platform, roboadvisors etc.), they are ill-suited to a large part of the population. At a time when these tools are becoming ever more numerous, many people feel overwhelmed by the complexity of the financial world in which they live, and have difficulties making informed decisions: half of the population doesn’t have any financial goals defined (saving money, preparing its retirement, …). This underscores the need for a tool that helps people understand their own financial situation and recommends goals to achieve.The application is positioned as an interactive financial companion, transforming the crucial step of understanding one's financial situation. By merging advanced technologies with an intuitive user experience, Jared democratizes access to personalized financial information.Jared's innovative approach goes beyond raw data to analyze the financial psychology of each user. By integrating elements of behavioral finance and cognitive science, Jared deciphers the emotions and biases that influence financial decisions. The result is informed analysis and tailored recommendations that go beyond the numbers. Jared's content is tailored to the user's profile, assets and personality.1. Proactive financial education: Beyond simple notifications, Jared acts as an educational guide, providing contextual advice precisely when the user needs it. It transforms complex financial moments into learning opportunities, empowering users. 2. Simplicity and accessibility: By making complex financial information understandable and accessible, Jared democratizes financial management. Users benefit from a user-friendly interface that simplifies decision-making.3. Utilization of behavioral finance: We leverage insights from cognitive science not merely to acquaint ourselves with our users but to comprehensively understand them. We use unique psychometric tests specifically developed to identify hidden characteristics of user. This enables us to assess traits previously unexplored within the realm of finance, offering a deeper understanding of user behavior. 4. Unique competitive advantage in data: This competitive edge lies in our dynamic dataset. With an interactive nature, our dataset continually evolves, allowing us to refine the correlation between content and user profiles with each new data iteration. This agility empowers us to adapt our offerings in real-time, ensuring relevance and efficacy for our users.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Medicxi VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
Medicxi is a life sciences-focused investment firm, originally created at Index Ventures, a leading international venture capital firm with offices in London, San Francisco, Geneva, and St. Helier (Jersey).Francesco De Rubertis joined Index at the end of 1997 to launch the firm's life sciences practice and was joined in the following yearsby three partners: Kevin Johnson, Michèle Ollier and David Grainger. Over the years, Index raised a total of twelve funds, managed with separate life sciences and technology investment teams.In 2012, Index launched sector-specific venture funds for the first time, raising separately Index Ventures VI (technology focus) and Index Life VI (life sciences focus). Global Pharma GlaxoSmithKline (NYSE: GSK) and affiliates of Johnson & Johnson (Janssen; NYSE: JNJ) both partnered with Index by investing in Index Life VI. This was a key step in the path towards the founding of Medicxi as an independent venture firm. (read here)Medicxi started its operations in February 2016, with offices in London, Geneva and St Helier (Jersey). Giuseppe Zocco, co-founder of Index Ventures, joined Medicxi shortly thereafter to help build the firm’s late-stage platform and lead the launch of its first Medicxi Growth fund, MG1. (read here)Currently, the firm is actively investing its 2 most recent funds, Medicxi Ventures 1 (focus on early-stage companies) and Medicxi Growth 1 (focus on later stage companies), in addition to managing the entire portfolio of all prior Index life sciences investments.The firm is led by its five co-founders and Partners: Francesco, Kevin, Michèle, David and Giuseppe. Over the years, the five of them have collectively been involved in starting over seventy companies in several countries.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
  • Alys Pharmaceuticals — Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
Keiretsu Forum Northwest VC Fund · Seattle, Washington, United States
Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Series A, Seed, Funding Round
  • United States, Spain, Canada
Portfolio highlights
  • iQure Pharma — iQure Pharma preclinical and clinical drug development
  • Levered Learning — Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States.
  • Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
EarlyBird VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
EarlyBird is a postal snacking service that delivers healthy snacks to its users’ doorstep. It provides its users with TasteBox, 5 healthy snacks and 2 unique teas, to help them through the working week. Its TasteBox also contains music and art from up and coming artists. EarlyBird was launched in 2014 and is based in London, England.
Show more
Investment focus
  • Financial Services, FinTech, Health Care
  • Seed, Series A, Pre-Seed
  • Germany, Ireland, Romania
Portfolio highlights
  • Sikoia — Streamline your decision-making with centralized customer data, comprehensive case management, and automated risk evaluation without complicated integrations.
  • Noscendo — Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections.
  • Goodlegal — Goodlegal is the One-Stop-Shop for all your Legal needs. Get an out-of-the-box Legal Infrastructure Platform to handle all your problems.
John O’Shaughnessy Angel
John has over 30 years experience in the medical device industry and is one of the most experienced medical device leaders in Ireland. He ran Medtronic’s cardiovascular business in Galway for 15 years and was the founder and CEO of MedNova Ltd. MedNova pioneered embolic protection for endovascular treatment of carotid artery disease and gainedworldwide approval for its products. John serves as Chairman of Vistamed Limited and Cambus Teoranta, and he served as Non-Executive Director of IDA Ireland from 1995 to 2000. He was a founder of Croi, the West of Ireland Cardiac Foundation, a voluntary organization to support the fight against heart disease and stroke.
Show more
Investment focus
  • Medical, Health Diagnostics
  • Funding Round
  • Ireland
Portfolio highlights
  • Ceroflo — Ceroflo offers revolutionary advancement in the treatment of Intracranial Atherosclerotic Disease.
Invest Northern Ireland VC Fund · Belfast, Belfast, United Kingdom
Invest Northern Ireland is Northern Ireland's economic development agency. Their overall goal is to help create wealth for the benefit of the whole community by strengthening the economy and helping it grow.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Grant, Seed
  • United Kingdom, United States, Ireland
Portfolio highlights
  • TruCorp — TruCorp: Your source for lifelike Medical Training Equipment. Explore our intubation manikins & airway trainers. Request a free demo today!
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
  • CV6 Therapeutics — CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.
KBI Biopharma VC Fund · Durham, North Carolina, United States
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.With each of our 300+ client partners, we have worked closely to personalize and rapidly accelerate their drug developmentprograms. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.We have locations in Durham and Research Triangle Park (NC), Boulder and Louisville (CO), The Woodlands (TX), San Diego (CA), and Leuven, Belgium.
Show more
Investment focus
  • Biotechnology, Life Science, Medical
  • Seed, Series A, Series D
  • United States, Ireland
Portfolio highlights
  • Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
  • GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
  • ReForm Biologics — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
Investors by industry
Investors by country
Investors in Ireland by industry